Gsk Share Discussion Threads

[essentialinvestor] 30/11/2017 23:41

Was just about to list that on the Lloyd's board ).

[philanderer] 30/11/2017 23:39

;-)


"Jeremy Corbyn tells Morgan Stanley: 'You're right, we are a threat' "

Labour leader hits back after investment bank warned clients his party could pose as much of a risk to UK business as Brexit

[romeike] 30/11/2017 23:38

I agree, it almost doesn't matter, what matters is that in all probability we can expect a rally back to a sensible price and any who topped up will be very pleased

[ny boy] 30/11/2017 23:38

1225p it is s then, not much further to fall then, should we be bothered, err no, still collecting attractive quarterly divis.

[woodhawk] 30/11/2017 23:28

You probably could have said the same in October 2015, or December 2016 but in both instances the share price was significantly higher a few months later - and never went lower.

[tim 3] 30/11/2017 23:19

Chart looks horrid with all those red bars showing bears firmly in control,I hope not as I am long but fear they want to take it down to 1225 support area.

[woodhawk] 30/11/2017 19:49

All you hand-wringers and doom-mongers would have done better worrying at 1700p not 1300p!! Talk about 'missed the boat'!!

[eisler] 30/11/2017 19:34

Oh well, that recovery was very short-lived. Worried about how far this could fall now in light of recent developments...

[essentialinvestor] 30/11/2017 18:18

Yes there are a truck load of exemptions, a lot of those apply to individuals.

I can only go on the GSK CFO's comments, which I think were mentioned here.

[zho] 30/11/2017 18:12

>>The US corporate tax rate is 35% from memory>>

Yes, that's the headline rate, but there are thousands of exemption clauses e.g. I think I read today (on Bloomberg) that the tech giants are paying less than 20%.

John Mauldin (US economist writing on investment matters) favours a cut to 15% but only if all exemptions are removed: he reckons this would increase the tax take.

[essentialinvestor] 30/11/2017 18:06

Stronger GBP is a major headwind.

The US corporate tax rate is 35% from memory, the GOP proposal
is a strafing rate at 20%, so a significant cut.

[ny boy] 30/11/2017 17:56

Gsk went down when the pound was weaker and down when the pound got stronger against the US$ doh!

[essentialinvestor] 30/11/2017 17:48

Reports McCain will vote in favour of US tax reform sending Wall St.
to new records. If passed it's supportive for big $ earners.

[philanderer] 30/11/2017 17:44

That was a sh*te day for the portfolio. Only three out of sixteen just going the right way... MKS, IMB and DOM.


Added a few GSK @ 1282p.

£ at a two month high against the $ and €

[buywell3] 30/11/2017 17:34

What the powers that be do not want you to know

[woodhawk] 30/11/2017 16:24

Sold yesterday for 1339p, bought 'em back today for 1279p. Ridiculous - but thanks!

[amt] 30/11/2017 16:20

Share price back where it was twenty years ago by the way.

[amt] 30/11/2017 16:16

The large Director buys at over 15 quid only 7 weeks ago and the possibility of Unilever coming back with another offer plus over 6% Divi should stop it falling much further although its hard to catch a falling knife.

[woodhawk] 30/11/2017 16:00

Ah, all the usual suspects have crawled back out from under their stones. Must be buying time!

[amt] 30/11/2017 16:00

It looks like capitulation after a long fall.

[romeike] 30/11/2017 15:58

This drop today is purely related to the FTSE, most of the FTSE started dropping about 14:00 and GSK started sliding 30 mins later with the same tiny bounce not long after 15:00

@Stewart64 I did notice Astra Zeneca had slipped earlier this week, I sold out there a while back, prefer the current underdogs GSK and Shire.

[stewart64] 30/11/2017 15:53

Starting to make Astrazeneca ( still close to annual highs) a bit expensive..at the very least one hell of risk.